IkT-1427

N/A

Report date: 2023/09/21 17:19:24
NME

Base Information

Drug NameIkT-1427
Drug Alias NameIkT-1427IkT-01427
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-tyrosine kinases inhibitorsVirus internalization inhibitors
TargetsProtein-tyrosine kinases
Therapy Area/IndicationsLeukoencephalopathy, Progressive Multifocal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInhibikase Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesInhibikase Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLeukoencephalopathy, Progressive Multifocal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A